Pharming Group N.V. (PHAR) Short term Debt (2019 - 2020)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Pharming (PHAR) has disclosed Short term Debt for 2 consecutive years, with $24.3 million as the latest value for Q4 2020.

• For the quarter ending Q4 2020, Short term Debt rose 22.95% year-over-year to $24.3 million, compared with a TTM value of $24.3 million through Dec 2020, up 22.95%, and an annual FY2020 reading of $25.0 million, up 25.0% over the prior year.
• Short term Debt was $24.3 million for Q4 2020 at Pharming, up from $19.7 million in the prior quarter.
• Across five years, Short term Debt topped out at $24.3 million in Q4 2020 and bottomed at $19.7 million in Q4 2019.

Peer Comparison